StockData
Progyny, Inc. logo

Progyny, Inc. (PGNY) stock

PGNYNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 19/304% above fair value
$36.71−0.44 (-1.18%)

Close on Nov 17, 2026Market cap $2.82BP/E 39.9Yield –

Progyny r&d expenses

Research and development expenses are spending on new products and technology.

Progyny's R&D Expenses for the twelve months ending Jun 30, 2026 was $11.80M. For fiscal 2025 it was $9.50M.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$9.50M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$3.30M+43.5%
Q1 FY2026Mar 31, 2026$2.80M+86.7%
Q4 FY2025Dec 31, 2025$3.10M–
Q3 FY2025Sep 30, 2025$2.60M–
Q2 FY2025Jun 30, 2025$2.30M–
Q1 FY2025Mar 31, 2025$1.50M–

More Progyny figures

See a number that looks wrong?